A Autret

1.2k total citations
43 papers, 780 citations indexed

About

A Autret is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, A Autret has authored 43 papers receiving a total of 780 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 11 papers in Surgery. Recurrent topics in A Autret's work include Pancreatic and Hepatic Oncology Research (11 papers), Neuroendocrine Tumor Research Advances (7 papers) and Esophageal Cancer Research and Treatment (4 papers). A Autret is often cited by papers focused on Pancreatic and Hepatic Oncology Research (11 papers), Neuroendocrine Tumor Research Advances (7 papers) and Esophageal Cancer Research and Treatment (4 papers). A Autret collaborates with scholars based in France, Italy and Canada. A Autret's co-authors include Olivıer Turrini, Jean‐Robert Delpéro, D. Saudeau, Jean‐Marie Boher, Alain Sauvanet, Philippe Bachellier, Cécile Marchal, L. Pourcelot, Nicolas Régenet and François Paye and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

A Autret

41 papers receiving 762 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Autret France 14 477 343 297 269 147 43 780
Dianrong Xiu China 19 525 1.1× 245 0.7× 272 0.9× 325 1.2× 95 0.6× 98 944
Lars‐Erik Tisell Sweden 17 258 0.5× 101 0.3× 206 0.7× 404 1.5× 123 0.8× 23 975
D Arsène Romania 13 294 0.6× 255 0.7× 115 0.4× 191 0.7× 37 0.3× 48 642
Marilena Bellò Italy 15 308 0.6× 235 0.7× 117 0.4× 229 0.9× 197 1.3× 29 893
Mitsuya Iwafuchi Japan 15 234 0.5× 170 0.5× 219 0.7× 275 1.0× 81 0.6× 29 613
Nassif B. N. Ibrahim United Kingdom 14 382 0.8× 143 0.4× 347 1.2× 184 0.7× 121 0.8× 18 672
J A Norton United States 13 483 1.0× 188 0.5× 486 1.6× 351 1.3× 247 1.7× 16 940
Nikos Courcoutsakis Greece 12 130 0.3× 176 0.5× 96 0.3× 211 0.8× 111 0.8× 26 527
Carney Ja United States 16 246 0.5× 111 0.3× 337 1.1× 446 1.7× 309 2.1× 23 1.0k
H Carrasco United States 9 133 0.3× 214 0.6× 88 0.3× 139 0.5× 83 0.6× 12 542

Countries citing papers authored by A Autret

Since Specialization
Citations

This map shows the geographic impact of A Autret's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Autret with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Autret more than expected).

Fields of papers citing papers by A Autret

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Autret. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Autret. The network helps show where A Autret may publish in the future.

Co-authorship network of co-authors of A Autret

This figure shows the co-authorship network connecting the top 25 collaborators of A Autret. A scholar is included among the top collaborators of A Autret based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Autret. A Autret is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rochigneux, Philippe, A Autret, Jérôme Guiramand, et al.. (2022). Impact of fiducial markers placement on the delineation of target volumes in radiation therapy for oesophageal cancer: FIDUCOR study. Frontiers in Oncology. 12. 1012712–1012712. 2 indexed citations
2.
Giovannini, Marc, A Autret, Christian Pésenti, et al.. (2021). Preoperative EUS evaluation of the response to neoadjuvant therapy for gastric and esophagogastric junction cancer is correlated with survival: A single retrospective study of 97 patients. Endoscopic Ultrasound. 10(2). 103–103. 9 indexed citations
3.
Duconseil, Pauline, Mustapha Adham, Alain Sauvanet, et al.. (2018). Fukuoka-Negative Branch-Duct IPMNs: When to Worry? A Study from the French Surgical Association (AFC). Annals of Surgical Oncology. 25(4). 1017–1025. 18 indexed citations
4.
Annède, Pierre, A Autret, Pierre Fau, et al.. (2018). Multivariate normal tissue complication probability modeling of vaginal late toxicity after brachytherapy for cervical cancer. Brachytherapy. 17(6). 922–928. 8 indexed citations
5.
Guérin, Mathilde, Keyvan Rezaï, Nicolás Isambert, et al.. (2017). PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer. European Journal of Cancer. 86. 28–36. 45 indexed citations
6.
Delpéro, Jean‐Robert, Florence Le Jeune, Philippe Bachellier, et al.. (2017). Prognostic Value of Resection Margin Involvement After Pancreaticoduodenectomy for Ductal Adenocarcinoma. Annals of Surgery. 266(5). 787–796. 71 indexed citations
7.
Godat, Sébastien, Fabrice Caillol, A Autret, et al.. (2017). Endotherapy in case of relapse of neoplastic Barrett’s esophagus after successful initial endoscopic resection. Surgical Endoscopy. 31(9). 3703–3710. 1 indexed citations
8.
9.
10.
Niccoli, Patricia, et al.. (2016). Systemic chemotherapy with FOLFOX in metastatic grade 1/2 neuroendocrine cancer. Molecular and Clinical Oncology. 6(1). 44–48. 18 indexed citations
11.
Oziel-Taïeb, Sandrine, Marine Gilabert, A Autret, et al.. (2015). Treatment of Pancreatic Adenocarcinoma in Elderly Patients over 75 Years of Age: A Retrospective Series of 129 Patients. Journal of Gastrointestinal Cancer. 47(1). 15–19. 5 indexed citations
12.
Caillol, Fabrice, Erwan Bories, A Autret, et al.. (2014). Evaluation of pCLE in the bile duct: final results of EMID study. Surgical Endoscopy. 29(9). 2661–2668. 26 indexed citations
13.
Birnbaum, David Jérémie, Olivıer Turrini, Jacques Ewald, et al.. (2014). Pancreatic neuroendocrine tumor: A multivariate analysis of factors influencing survival. European Journal of Surgical Oncology. 40(11). 1564–1571. 29 indexed citations
14.
Birnbaum, David Jérémie, Olivıer Turrini, Luca Viganò, et al.. (2014). Surgical Management of Advanced Pancreatic Neuroendocrine Tumors: Short-Term and Long-Term Results from an International Multi-institutional Study. Annals of Surgical Oncology. 22(3). 1000–1007. 74 indexed citations
15.
Delpéro, Jean‐Robert, Philippe Bachellier, Nicolas Régenet, et al.. (2013). Pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a French multicentre prospective evaluation of resection margins in 150 evaluable specimens. HPB. 16(1). 20–33. 130 indexed citations
16.
Prébet, Thomas, Estelle Jean, A Autret, et al.. (2012). Combination of cytarabine and topotecan in patients treated for acute myeloid leukemia with persistent disease after frontline induction. Leukemia & lymphoma. 53(11). 2186–2191. 6 indexed citations
17.
Debiais, Séverine, Bruno Giraudeau, D. Perrotin, et al.. (2007). Création d’une filière neuro-vasculaire régionale : évaluation de la prise en charge à 18 mois. Revue Neurologique. 163(8-9). 817–822. 6 indexed citations
18.
Toffol, Bertrand de, et al.. (1997). [Paraneoplastic encephalomyeloneuritis with anti-Hu antibodies and cancer of the rectum].. PubMed. 153(2). 135–7. 3 indexed citations
19.
Autret, A, et al.. (1987). STROKE RISK IN PATIENTS WITH CAROTID STENOSIS. The Lancet. 329(8538). 888–890. 113 indexed citations
20.
Autret, A, et al.. (1982). Amiodaron Neuropathy: Further Arguments for Human Drug-Induced Neurolipidosis. European Neurology. 21(1). 65–68. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dianrong Xiu Breakdown of academic impact, for papers by Lars‐Erik Tisell Breakdown of academic impact, for papers by D Arsène Breakdown of academic impact, for papers by Marilena Bellò Breakdown of academic impact, for papers by Mitsuya Iwafuchi Breakdown of academic impact, for papers by Nassif B. N. Ibrahim Breakdown of academic impact, for papers by J A Norton Breakdown of academic impact, for papers by Nikos Courcoutsakis Breakdown of academic impact, for papers by Carney Ja Breakdown of academic impact, for papers by H Carrasco
Rankless by CCL
2026